InsidersTradesSigma
한미약품 Stock: price and insider trades · South Korea · DART (FSS)
Track the 한미약품 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 한미약품 has logged 2 public disclosures. Market capitalisation: €5,211.6bn. The latest transaction was filed on 10 June 2026 (Other). Among the most active insiders: 국민연금공단. Every trade is accessible without an account.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 한미약품 Buy (bullish), based on 15 analysts. Average price target: ₩596,667.
10Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 9,883 of 25,443 companies
57.6
score / 100
Value44
Quality72
FCF yld1.8%
Earn yld3.2%
EV/EBITDA17.5x
ROE14%
Gross mgn57%
Net mgn11%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 10 June 2026